Concepedia

Joyce D. Fingeroth

JD

Statistics

Publications

39

Citations

3.9K

H-Index

28

Active since

1984

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Dana-Farber Cancer Institute

Brigham and Women's Hospital

University of Massachusetts Chan Medical School

Joyce D. Fingeroth is an author at Beth Israel Deaconess Medical Center specializing in life sciences, molecular virology, and virology.

ORCID

Publications per year

1984–2020

39

Publications

39

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Joyce D. Fingeroth, Joachim Weis, Thomas F. Tedder et al. · Proceedings of the National Academy of Sciences · 1984 · 940 citations · Full text

, , +13

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus

Young-Kwon Hong, Kimberly E. Foreman, Jay W. Shin et al. · Nature Genetics · 2004 · 378 citations

, , +16

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.

Gordon J. Freeman, G S Gray, Claude Gimmi et al. · The Journal of Experimental Medicine · 1991 · 347 citations · Full text

, , +17

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignancies

Susan P. Perrine, Olivier Hermine, Trudy N. Small et al. · Blood · 2006 · 294 citations · Full text

, , +11

The Epstein-Barr Virus (EBV)-Encoded Protein Kinase, EBV-PK, but Not the Thymidine Kinase (EBV-TK), Is Required for Ganciclovir and Acyclovir Inhibition of Lytic Viral Production

Stacy R. Hagemeier, Joyce D. Fingeroth, Edward Gershburg et al. · Journal of Virology · 2010 · 167 citations

, , +16

1–5 of 39